Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | FNTA | P49354 | 8/20 | 0.41 |
| ▸ | FNTB | P49356 | 8/20 | 0.41 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.41 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4284629 | 0.93 | LMNA (0.48) | LMNAFNTAFNTBPGGT1BMME | |
| SCHEMBL4284627 | 0.93 | LMNA (0.48) | LMNAFNTAFNTBPGGT1BMME | |
| SCHEMBL29497578 | 0.92 | METAP2 (0.40) | LMNAFNTAFNTBPGGT1BMETAP2 | |
| SCHEMBL30011190 | 0.92 | LMNA (0.51) | LMNAFNTAFNTBPGGT1BFOLH1 | |
| SCHEMBL29630632 | 0.90 | LMNA (0.46) | LMNAFNTAFNTBPGGT1BMME | |
| SCHEMBL30112746 | 0.89 | METAP2 (0.41) | LMNAFNTAFNTBPGGT1BMETAP2 | |
| SCHEMBL30575172 | 0.89 | LMNA (0.48) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL30272454 | 0.88 | ACE (0.49) | FNTAFNTBPGGT1B | |
| SCHEMBL30051849 | 0.88 | FOLH1 (0.53) | LMNAFNTAFNTBPGGT1BMETAP2 | |
| SCHEMBL29486967 | 0.88 | LMNA (0.42) | LMNAFNTAFNTBPGGT1BMETAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3086 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747266-A1 | NOVEL INSECT INHIBITORY PROTEINS | Monsanto Technology LLC (US) | 2026-05-27 | — | — | EP | disclosed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-113881680-B | T cell antigen receptor, multimeric complex thereof, and preparation method and application thereof | 华夏英泰（北京）生物技术有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-119709844-B | Application of rice gene OsbHLH176,176 in regulation and control of cold resistance | 南京农业大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-113853432-B | Novel polypeptides for producing patchoulol and/or drimenol compounds | 弗门尼舍有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-115335392-B | Inhibition of shade-avoidance response in plants | 成对植物服务股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12618082-B2 | Engineered muscle targeting compositions | THE BROAD INSTITUTE, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-12595440-B2 | 2709 alkali protease mutant modified based on molecular dynamics calculation and use thereof | SHANXI YONG FOREVER TECHNOLOGY CO., LTD (CN) | 2026-04-07 | — | — | US | disclosed |
| EP-4074831-B1 | NOVEL POLYPEPTIDE, FUSION POLYPEPTIDE, AND ANTIBIOTIC AGAINST GRAM-NEGATIVE BACTERIA COMPRISING SAME | LYSENTECH CO LTD (KR) | 2026-01-21 | — | — | EP | disclosed |
| US-12503493-B2 | Rabbit haemorrhagic disease virus (RHDV) vaccines | VST LLC (US) | 2025-12-23 | — | — | US | disclosed |
| WO-2022020616-A1 | ENGINEERED MUSCLE TARGETING COMPOSITIONS | THE BROAD INSTITUTE, INC. (US) | 2022-01-27 | — | — | WO | disclosed |
| CN-111849930-B | Mi-2 recombinant antigen and preparation method and application thereof | 珠海丽珠试剂股份有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-113969272-A | Conjugate of mutant protease 3 and biotin and preparation method and application thereof | 苏州携创生物技术有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-111073875-B | Wheat haploid inducing gene and application thereof | 中国农业大学 | 2022-01-25 | — | — | CN | disclosed |
| CN-113957060-A | Glutamine synthetase mutant and application thereof | 四川天豫兴禾生物科技有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113966401-A | HTRA1 modulation for the treatment of AMD | 犹他大学研究基金会 | 2022-01-21 | — | — | CN | disclosed |
| CN-113952338-A | Methods of treating gefitinib resistant cancers | 综合医院公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113952459-A | Methods of treating gefitinib resistant cancers | 综合医院公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113957065-A | Sucrose isomerase with high conversion rate and application thereof | 南京诺云生物科技有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113957061-A | Administration of kynurenine depleting enzymes for tumor therapy | 得克萨斯大学体系董事会 | 2022-01-21 | — | — | CN | disclosed |